KALA vs WMB · $54.3M cap vs P/E 31, rev $6.08B
Kala Pharmaceuticals Inc (KALA) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported WMB revenue for 2026-06-30 was $6.08B. Net income was $1.69B. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
KALA currently screens at market cap $54.3M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the KALA and WMB stock pages for the full models.
Not investment advice.